8. COVID-19 vaccination campaign in Geneva
The organisation of the vaccination campaign is likely to evolve according to the number of vaccines and the number of people registered. As a result, at present, vaccination appointments are only granted to people aged 45+, adults under 45 with high vulnerability criteria (with one or more chronic illnesses at high risk of complication) and health workers in nursing homes or hospitals who are in contact with people at high risk.
|23 December 2020||Delivery of the first consignment of Pfizer* vaccines and beginning of the vaccination of people aged 75 years+ in a residential home for the elderly (IEPA) (as of December 28th)|
|As of 4 January 2021||Delivery of the second consignment of Pfizer vaccines and beginning of the vaccination of people aged 75 years+ in social medical institutions (EMS), in certain units of the HUG and in three vaccination centres (M3 Sanitrade, Clinique et permanence d'Onex, Clinique de Carouge|
|15 January||Delivery of the first consignment of Moderna* vaccines|
|As of 18 January 2021||Delivery of the third consignment of Pfizer vaccines
People aged 75+ and highly vulnerable adults, regardless of their age, have priority for vaccination registration
|20 January||Opening of a vaccination centre at the Geneva University Hospitals of Geneva (HUG)|
|25 January||Opening of two new vaccination centres: Clinique Générale Beaulieu and Clinique des Grangettes|
|23 February||Following the delivery of 5,000 doses of vaccine, the vaccination programme in vaccination centres is opened to adults with high vulnerability criteria (who have requested and received a certificate from their general practitioner proving that they have priority access for vaccination against COVID-19) and also, on their workplace, to health workers in contact with high-risk people|
|17 March||People aged 65+ have priority for vaccination registration|
Opening of a new vaccination centre on the Hospital de la Tour site
Opening of vaccination to staff and residents in facilities for people with disabilities
|April and May||
Increase in vaccine deliveries: between 18,000 and 20,000 doses should be supplied each week in Geneva (half Moderna and half Pfizer), making it possible to double the number of vaccinations per week and to gradually extend vaccination to other population groups depending on registration, and then to the entire population
|6 April||Opening of the vaccination to all health professionals and socio-sanitary categories in contact with patients or vulnerable persons (Group II)|
|12 April||Opening of the vaccination to 45-54 and 55-64 age groups|
|19 April||Opening of a vaccine site at Palexpo with a potential injection capacity of 4,000 doses per day, which will be managed by the association of Geneva doctors (AMGe) and the association of pharmacy owners of the canton of Geneva (PharmaGeneve)|
|3 May||Launch of a project for the co-management by the Pharmacie Populaire group of the COVID-19 vaccination schedule (project intended for vulnerable people aged 65+ for whom computer tools present a technological barrier with regards to their online registration.|
Opening of the vaccination centre in Cologny (Clinique Hirslanden-Grangettes).
Launch of two pilot projects for registration and vaccination in pharmacies (Pharmacie Bleue in Vésenaz and Pharmacie du Mandement in Satigny).
*Vaccines against COVID-19
In Switzerland, the vaccines currently used in the COVID-19 vaccination campaign are manufactured by the companies Pfizer/BioNTech and Moderna.